Data as of Apr 17
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for China Cord Blood Corp have a median target of 5.80, with a high estimate of 7.00 and a low estimate of 5.00. The median estimate represents a +35.20% increase from the last price of 4.29.
The current consensus among 4 polled investment analysts is to Buy stock in China Cord Blood Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.